BCL-Panels-Biomerieux-Micro-Sole Source

The Alabama Department of Public Health's Bureau of Clinical Laboratories is conducting a sole source procurement for specialized medical diagnostic panels from BioMerieux. Specifically, the agency is seeking to acquire two distinct test panel types: 423742 BIOFIRE RP2.1 Panel (30 Tests IVD) and RFIT-ASY-0116 FILMARRAY GI Panel (30 Tests), with mandatory shipping included. This procurement is critical for maintaining laboratory testing capabilities, with strict requirements that no alternative or substitute products will be accepted. The solicitation emphasizes the urgent operational need, mandating that the order must be ready to ship within 10 business days of purchase order award. The contract opportunity is posted with a solicitation date of February 28, 2025, and a response deadline of March 5, 2025. BioMerieux is the exclusive approved vendor, and the Bureau of Clinical Laboratories reserves the right to withhold award based on potential budget restrictions.

No specific set-aside designations or restrictions for disadvantaged enterprises are explicitly mentioned in the available documentation. The procurement appears to be a direct, targeted acquisition focused solely on BioMerieux diagnostic panels for clinical laboratory testing. While the exact budget range is not specified, the procurement seems to be for a focused, specialized medical diagnostic product line. The standard boilerplate document indicates that potential vendors must be registered in the Alabama Buys system, comply with E-Verify program requirements if employing Alabama workers, and be prepared to accept various electronic payment methods. Vendors must also be prepared for potential cost analysis and price reasonableness evaluations by the state's Chief Procurement Officer. The sole source nature of the procurement suggests a highly specialized, mission-critical medical diagnostic need that cannot be met through competitive bidding.